Haier Biomedical Drives Global Leap of Life Science Infrastructure: International Business Hits Record High for 36% of Annual Revenue in 2025
AI-powered growth surges as Haier Biomedical scales from product coverage to premium brand leadership, building a global life science tools and intelligent productivity platform QINGDAO, China, April 30, 2026 /PRNewswire/ -- Haier Biomedical...
GIGABYTE Wins Red Dot Design Award Across Its AI Product Lineup
TAIPEI, April 30, 2026 /PRNewswire/ -- GIGABYTE, the world's leading computer brand, announces that its AI product lineup has been recognized by the Red Dot Design Award across graphics card, motherboard, and laptop categories, highlighting a...
2026 ESMO GC | Mabwell to Present Latest Clinical Data on 9MW2821 for Cervical Cancer in Oral and Poster Presentations
SHANGHAI, April 30, 2026 /PRNewswire/ -- Mabwell (688062.SH, 02493.HK), an innovation-driven biopharmaceutical company with a fully integrated industry chain, today announced that two latest clinical study results of its novel Nectin‑4 targeting ADC...
Elite Robots Launches RoboBarista to Revolutionize Self-Service Coffee Experiences in Commercial and Public Spaces
SHANGHAI, April 30, 2026 /PRNewswire/ -- Elite Robots, a global leader in collaborative robotics, today announced RoboBarista, a fully autonomous coffee station designed for high-traffic commercial spaces. Combining precision cobot technology with...
Driving the Global Food Revolution: Japan's Cutting-Edge Food Processing Technology Takes Center Stage
FOOMA JAPAN 2026 to Showcase Next-Generation Solutions Shaping the Future of Food Processing and Global Quality Standards TOKYO, April 30, 2026 /PRNewswire/ -- The Japan Food Machinery Manufacturers' Association (FOOMA) will host FOOMA JAPAN 2026,...
MetaComp Group Completes Tether Gold (XAUT) Proof-of-Concept and Launches Commercial Tokenised Gold Capabilities for Institutional Clients
MetaComp Group validates tokenised gold across three use cases — cross-border payments, long-term value preservation, and gold-collateralised working capital — following a live proof-of-concept that successfully executed a US$10,000 equivalent...
D3 Bio Presents KRAS Pipeline Updates at AACR 2026; Elisrasib (D3S-001), a Next-Generation KRAS G12C Inhibitor, Shows Strong Phase 2 Efficacy Across Multiple Tumor Types
Elisrasib monotherapy demonstrates notable efficacy in three major tumor types at its recommended phase 2 dose (RP2D , 600 mg QD). Phase 2 clinical outcomes include: 2L+ KRAS G12Ci–naive NSCLC: ORR of 58.8%, mPFS of 12.2 months 2L+ colorectal cancer...
Traveloka dаta: Southeast Asia Travelers Book 25% More on Double-Digit Dates, Even Without Sales
SINGAPORE, April 30, 2026 /PRNewswire/ -- Traveloka data across five markets reveals that double-digit dates have become a self-organizing travel calendar, with organic booking lifts recorded even when no campaign was running. The platform's biggest...